Use blood from each patient to compare patients to healthy relatives and examine:
- Genome
- Gene expression
- Metabolomics
- Proteomics
- Cytokines
- Microbiome
- Autoantibodies
By comparing patients to healthy blood relatives, we are more likely to understand what genes cause or contribute to the development of ME/CFS. This data will also be integrated with the SIPS data.